Head-to-Head in Heart Failure: Comparative Insights on Empagliflozin and Dapagliflozin
Heart failure (HF) remains a leading cause of morbidity and mortality globally, with increasing prevalence driven by aging populations and comorbidities such as diabetes mellitus. Recent advances have highlighted sodium-glucose cotransporter-2 (SGLT2) inhibitors, particularly empagliflozin and dapag...
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | , , |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
MDPI AG
2025-10-01
|
| Σειρά: | Biomedicines |
| Θέματα: | |
| Διαθέσιμο Online: | https://www.mdpi.com/2227-9059/13/10/2422 |
| Ετικέτες: |
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|